retatrutide description Unapproved weight loss drug causes extreme side effects Retatrutide vs. Tirzepatide: The Next-Gen

Men only

How the Savings Card Works: Your insurance processes the claim first and determines your copay or coinsurance amount

According to a report from WHO, in 2022, approximately 830 million people worldwide had diabetes, while 1 in 8 individuals globally were affected by obesity

Before starting a GLP-1 drug, consider asking: "How are we going to track my muscle mass during treatment?" Getting a baseline DXA scan before starting and repeating it every 36 months gives you data that a standard scale cannot provide

The lipid benefits of GLP-1 therapy should be viewed as complementary rather than alternative to evidence-based lipid-lowering treatment

2022;45.:S144-s74